MassMutual Private Wealth & Trust’s DiaMedica Therapeutics DMAC Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34K	Hold	4,824	–	–	﹤0.01%	926
2026 Q1	$32.7K	Hold	4,824	–	–	﹤0.01%	913
2025 Q4	$38.4K	Hold	4,824	–	–	﹤0.01%	877
2025 Q3	$33.1K	Hold	4,824	–	–	﹤0.01%	931
2025 Q2	$18.8K	Hold	4,824	–	–	﹤0.01%	1128
2025 Q1	$18.3K	Hold	4,824	–	–	﹤0.01%	1061
2024 Q4	$26.2K	Hold	4,824	–	–	﹤0.01%	918
2024 Q3	$20.2K	Hold	4,824	–	–	﹤0.01%	901
2024 Q2	$14.2K	Hold	4,824	–	–	﹤0.01%	956
2024 Q1	$13.4K	Hold	4,824	–	–	﹤0.01%	947
2023 Q4	$13.7K	Hold	4,824	–	–	﹤0.01%	911
2023 Q3	$12.4K	Hold	4,824	–	–	﹤0.01%	926
2023 Q2	$20.8K	Hold	4,824	–	–	﹤0.01%	753
2023 Q1	$7.38K	Hold	4,824	–	–	﹤0.01%	1034
2022 Q4	$8K	Hold	4,824	–	–	﹤0.01%	838
2022 Q3	$6K	Hold	4,824	–	–	﹤0.01%	883
2022 Q2	$10K	Hold	4,824	–	–	﹤0.01%	715
2022 Q1	$12K	Hold	4,824	–	–	﹤0.01%	701
2021 Q4	$18K	Hold	4,824	–	–	﹤0.01%	619
2021 Q3	$19K	Buy	+4,824	New	+$18.5K	﹤0.01%	607

Other funds holding DMAC

Members Wealth Media, Pennsylvania $182M AUM 15.09% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

MassMutual Private Wealth & Trust's DMAC Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 4,824 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #926.

MassMutual Private Wealth & Trust first reported a position in DMAC in Q3 2021 and has held it in 20 quarters since. The position peaked at $38.4K in Q4 2025. 6 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

MassMutual Private Wealth & Trust held 4,824 shares of DiaMedica Therapeutics worth $34K as of Q2 2026.
MassMutual Private Wealth & Trust left its DiaMedica Therapeutics share count unchanged in Q2 2026.
DiaMedica Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #926 holding.
MassMutual Private Wealth & Trust first reported a position in DiaMedica Therapeutics in Q3 2021 and has held it in 20 quarters since.
MassMutual Private Wealth & Trust's DiaMedica Therapeutics position peaked at $38.4K in Q4 2025.
6 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.